Foster James D, Vaughan Roxanne A
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks ND 58202 United States.
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks ND 58202 United States.
J Chem Neuroanat. 2017 Oct;83-84:10-18. doi: 10.1016/j.jchemneu.2016.10.004. Epub 2016 Nov 9.
The dopamine transporter (DAT) is a plasma membrane phosphoprotein that actively translocates extracellular dopamine (DA) into presynaptic neurons. The transporter is the primary mechanism for control of DA levels and subsequent neurotransmission, and is the target for abused and therapeutic drugs that exert their effects by suppressing reuptake. The transport capacity of DAT is acutely regulated by signaling systems and drug exposure, providing neurons the ability to fine-tune DA clearance in response to specific conditions. Kinase pathways play major roles in these mechanisms, and this review summarizes the current status of DAT phosphorylation characteristics and the evidence linking transporter phosphorylation to control of reuptake and other functions. Greater understanding of these processes may aid in elucidation of their possible contributions to DA disease states and suggest specific phosphorylation sites as targets for therapeutic manipulation of reuptake.
多巴胺转运体(DAT)是一种质膜磷蛋白,可将细胞外多巴胺(DA)主动转运到突触前神经元中。该转运体是控制DA水平及随后神经传递的主要机制,也是滥用药物和治疗药物的作用靶点,这些药物通过抑制再摄取发挥作用。DAT的转运能力受到信号系统和药物暴露的急性调节,使神经元能够根据特定条件微调DA清除率。激酶途径在这些机制中起主要作用,本综述总结了DAT磷酸化特征的现状以及将转运体磷酸化与再摄取控制和其他功能联系起来的证据。对这些过程的更深入理解可能有助于阐明它们对DA疾病状态的可能贡献,并提出特定的磷酸化位点作为再摄取治疗操作的靶点。